AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glyzanda M 0.5mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

GPA Exim Private Limited

Salt Composition

Glimepiride (0.5mg) + Metformin (500mg)

Overview Glyzanda M 0.5mg/500mg Tablet

Diabexe Duo 0.5mg/500mg tablets are classified as antidiabetic medications, combining two active ingredients to manage type 2 diabetes in adults. This medication assists in regulating blood glucose levels. Diabexe Duo should be administered with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose, increasing the risk of complications such as nephropathy, retinopathy, neuropathy, and limb loss. This medication is part of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and carry a rapid-acting glucose source like sweets or juice. Alcohol consumption elevates hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your doctor before starting treatment. Consult your physician before use during pregnancy or breastfeeding. Regular blood glucose monitoring and periodic blood tests (to check blood cell counts and liver function) are recommended.

Primary Ingredients of Glyzanda M 0.5mg/500mg Tablet

No text was provided to rewrite.

Uses of Glyzanda M 0.5mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Glyzanda M 0.5mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the Glyzanda M 0.5mg/500mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

Common Side effects of Glyzanda M 0.5mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glyzanda M 0.5mg/500mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the Glyzanda M 0.5mg/500mg tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with food.

How Glyzanda M 0.5mg/500mg Tablet works:

Glyzanda M tablets (0.5mg/500mg) combine glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, impeding intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glyzanda M 0.5mg/500mg Tablet with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Glyzanda M 0.5mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against the risks prior to prescribing. Seek medical advice before use.

Breast feedingBreast feedingUNSAFE

Lactation and Glyzanda M 0.5mg/500mg tablets are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glyzanda M 0.5mg/500mg tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. Glyzanda M 0.5mg/500mg tablets are contraindicated in individuals with severe kidney disease. Close monitoring of kidney function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glyzanda M 0.5mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, a low initial dose is typical; however, its use is contraindicated in cases of severe liver dysfunction.

What if you forget to take Glyzanda M 0.5mg/500mg Tablet :

Should you forget to take a Glyzanda M 0.5mg/500mg Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glyzanda M 0.5mg/500mg Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Glyzanda M 0.5mg/500mg Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Glyzanda M 0.5mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glyzanda M 0.5mg/500mg Tablets and seek immediate medical attention.
Glyzanda M 0.5mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with a healthy diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 DM.
Glyzanda M 0.5mg/500mg Tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged Glyzanda M 0.5mg/500mg Tablet use can lead to Vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental Vitamin B12 intake is recommended annually by some researchers.
Glyzanda M 0.5mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glyzanda M 0.5mg/500mg tablets and alcohol is unsafe. Alcohol may exacerbate the drug's blood sugar-lowering effect, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Glyzanda M 0.5mg/500mg Ta...
25
MRP 30
16% off